Lisdexamphetamine versus methylphenidate for paediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes (LAMAinDiab): protocol for a multicentre, randomised cross-over clinical trial in an outpatient telemedicine-supported setting
Arkadiusz Michalak, Jędrzej Chrzanowski, Hanna Kuśmierczyk-Kozieł, Ewa Klejman, Katarzyna Błaziak, Beata Mianowska, Agnieszka Szadkowska, Agata P Chobot, Przemysława Jarosz-Chobot, Małgorzata Myśliwiec, Iwona Makowska, Anna Kalenik, Monika Zamarlik, Tomasz Wolańczyk, Wojciech Fendler, Agnieszka Butw · 2023
Read Lisdexamphetamine versus methylphenidate for paediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes (LAMAinDiab): protocol for a multicentre, randomised cross-over clinical trial in an outpatient telemedicine-supported setting by Arkadiusz Michalak, Jędrzej Chrzanowski, Hanna Kuśmierczyk-Kozieł, Ewa Klejman, Katarzyna Błaziak, Beata Mianowska, Agnieszka Szadkowska, Agata P Chobot, Przemysława Jarosz-Chobot, Małgorzata Myśliwiec, Iwona Makowska, Anna Kalenik, Monika Zamarlik, Tomasz Wolańczyk, Wojciech Fendler, Agnieszka Butw (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10728970.txt.
Description
Arkadiusz Michalak and co-authors lay out a trial protocol comparing two stimulant medicines in children who have both ADHD and type 1 diabetes. Their 2023 protocol notes that ADHD is reported more often in children with diabetes and can worsen its course. Treating the attention disorder well might help both brain and metabolism.
The multicentre trial runs in Polish diabetes centers with remote support. Children aged eight to sixteen enter after their guardians complete weeks of online behavior training. Each child then receives both medicines in turn, in random order, so the two can be compared within the same patient. Outcomes cover attention symptoms and diabetes control. A careful head-to-head in this doubly burdened group is missing from current care guidance.
Catalog record
| CREATOR | Arkadiusz Michalak, Jędrzej Chrzanowski, Hanna Kuśmierczyk-Kozieł, Ewa Klejman, Katarzyna Błaziak, Beata Mianowska, Agnieszka Szadkowska, Agata P Chobot, Przemysława Jarosz-Chobot, Małgorzata Myśliwiec, Iwona Makowska, Anna Kalenik, Monika Zamarlik, Tomasz Wolańczyk, Wojciech Fendler, Agnieszka Butw |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |